Trademark: 88731302
Word
RIOMET ER
Status Date
Monday, July 17, 2023
Filing Date
Wednesday, December 18, 2019
Published for Opposition
Tuesday, April 21, 2020
Abandoned Date
Monday, July 17, 2023
5 Pharmaceutical and medicinal preparations for use by humans in the treatment of diabetes
The mark consists of the words "Riomet ER" with three curved lines under the letter "R".
Color is not claimed as a feature of the mark.
"ER"
Jul 17, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 17, 2023
Abandonment - No Use Statement Filed
Jan 5, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 4, 2023
Sou Extension 5 Granted
Dec 15, 2022
Sou Extension 5 Filed
Jan 4, 2023
Case Assigned To Intent To Use Paralegal
Dec 15, 2022
Teas Extension Received
Jun 18, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 16, 2022
Sou Extension 4 Granted
Jun 16, 2022
Sou Extension 4 Filed
Jun 16, 2022
Teas Extension Received
Dec 16, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 14, 2021
Sou Extension 3 Granted
Dec 14, 2021
Sou Extension 3 Filed
Dec 14, 2021
Teas Extension Received
Jun 17, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 15, 2021
Sou Extension 2 Granted
Jun 15, 2021
Sou Extension 2 Filed
Jun 15, 2021
Teas Extension Received
Dec 17, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 15, 2020
Sou Extension 1 Granted
Dec 15, 2020
Sou Extension 1 Filed
Dec 15, 2020
Teas Extension Received
Jun 16, 2020
Noa E-Mailed - Sou Required From Applicant
Apr 21, 2020
Official Gazette Publication Confirmation E-Mailed
Apr 21, 2020
Published For Opposition
Apr 1, 2020
Notification Of Notice Of Publication E-Mailed
Mar 17, 2020
Approved For Pub - Principal Register
Mar 17, 2020
Assigned To Examiner
Dec 24, 2019
Notice Of Design Search Code E-Mailed
Dec 21, 2019
New Application Office Supplied Data Entered
Trademark Alertz updated from USPTO on 2030-01-24
